Postprandial Apolipoprotein B48 is Associated with Subclinical Atherosclerosis in Patients with Rheumatoid Arthritis.
Natalia Mena VázquezMarta Rojas-GimenezFrancisco Gabriel Jimenez NuñezSara Manrique ArijaJosé RiojaPatricia Ruiz-LimónInmaculada Ureña GarnicaManuel Castro-CabezasPedro ValdivielsoAntonio Fernandez-NebroPublished in: Journal of clinical medicine (2020)
Postprandial ApoB48 levels in patients with RA are higher than in controls. Postprandial ApoB48 and total ApoB levels and markers of severity, such as ACPAs, are associated with pathologic cIMT in patients with RA. Our findings could indicate that these atherogenic particles have a negative effect on the endothelium.